Susquehanna International Group’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,725
| Closed | -$42.6K | – | 13566 |
|
|
2023
Q4 | $42.6K | Hold |
5,725
| – | – | ﹤0.01% | 11775 |
|
|
2023
Q3 | $55.4K | Hold |
5,725
| – | – | ﹤0.01% | 11255 |
|
|
2023
Q2 | $58.6K | Hold |
5,725
| – | – | ﹤0.01% | 11268 |
|
|
2023
Q1 | $59.8K | Sell |
5,725
-45,000
| -89% | -$599K | ﹤0.01% | 11611 |
|
|
2022
Q4 | $649K | Sell |
50,725
-175
| -0.3% | -$2.6K | ﹤0.01% | 7199 |
|
|
2022
Q3 | $794K | Buy |
50,900
+48,825
| +2,353% | +$936K | ﹤0.01% | 7246 |
|
|
2022
Q2 | $42K | Sell |
2,075
-152
| -7% | -$3.8K | ﹤0.01% | 12073 |
|
|
2022
Q1 | $82K | Sell |
2,227
-514
| -19% | -$18.5K | ﹤0.01% | 12038 |
|
|
2021
Q4 | $99K | Sell |
2,741
-1,146
| -29% | -$60.4K | ﹤0.01% | 12161 |
|
|
2021
Q3 | $292K | Sell |
3,887
-1,002
| -20% | -$71.2K | ﹤0.01% | 10665 |
|
|
2021
Q2 | $429K | Buy |
4,889
+1,426
| +41% | +$136K | ﹤0.01% | 9951 |
|
|
2021
Q1 | $395K | Buy |
+3,463
| New | +$384K | ﹤0.01% | 10012 |
|
|
2019
Q3 | – | Sell |
-396
| Closed | -$117K | – | 10952 |
|
|
2019
Q2 | $117K | Buy |
396
+244
| +161% | +$86K | ﹤0.01% | 9531 |
|
|
2019
Q1 | $71K | Buy |
+152
| New | +$59K | ﹤0.01% | 8382 |
|
|
2018
Q3 | – | Sell |
-270
| Closed | -$53K | – | 10402 |
|
|
2018
Q2 | $53K | Buy |
270
+65
| +32% | +$12K | ﹤0.01% | 9259 |
|
|
2018
Q1 | $30K | Sell |
205
-111
| -35% | -$21.7K | ﹤0.01% | 9074 |
|
|
2017
Q4 | $75K | Buy |
316
+54
| +21% | +$11.2K | ﹤0.01% | 8796 |
|
|
2017
Q3 | $53K | Buy |
+262
| New | +$48.2K | ﹤0.01% | 8526 |
|
|
2017
Q2 | – | Sell |
-194
| Closed | -$58K | – | 9947 |
|
|
2017
Q1 | $58K | Buy |
+194
| New | +$57.1K | ﹤0.01% | 8560 |
|
Other funds holding CSCI
Susquehanna International Group's CSCI Position: Q3 2025 in Review
Susquehanna International Group sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2025, closing a stake of 11,504 shares — an estimated $39K sold.
Susquehanna International Group first reported a position in CSCI in Q1 2014 and held it in 24 quarters. The position peaked at $4.58M in Q1 2015. 2 funds tracked by Wall St. Rank hold CSCI as of Q3 2025.
- Susquehanna International Group reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
- Susquehanna International Group sold 11,504 COSCIENS Biopharma Inc. Common Stock shares in Q3 2025, an estimated $39K.
- Susquehanna International Group first reported a position in COSCIENS Biopharma Inc. Common Stock in Q1 2014 and held it in 24 quarters.
- Susquehanna International Group's COSCIENS Biopharma Inc. Common Stock position peaked at $4.58M in Q1 2015.
- 2 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2025.
Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.